Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Quality of Life × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 336 Colorectal Neoplasms 254 Rectal Neoplasms 185 Stomach Neoplasms 172 Pancreatic Neoplasms 109 Neoplasm Metastasis 107 Colonic Neoplasms 76 Neoplasms 72 Triple Negative Breast Neoplasms 53 Esophageal Neoplasms 50 Nasopharyngeal Carcinoma 32 Biliary Tract Neoplasms 31 Adenocarcinoma 28 Gallbladder Neoplasms 27 Cholangiocarcinoma 27 Carcinoma, Hepatocellular 25 Bile Duct Neoplasms 20 Adenocarcinoma Of Esophagus 19 Locally Advanced Rectal Cancer 17 Brain Neoplasms 17 Liver Neoplasms 14 Esophageal Squamous Cell Carcinoma 14 Colorectal Cancer Metastatic 14 Carcinoma, Non-Small-Cell Lung 14 Squamous Cell Carcinoma of Head and Neck 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Head and Neck Neoplasms 13 Gastrointestinal Neoplasms 13 Ovarian Neoplasms 12 Anus Neoplasms 12

Interventions

endostar protein 1 coenzyme Q10 1 apatinib 1 Yoga 1 Ubiquinone 1 Tamoxifen 1 Referral and Consultation 1 Palliative Care 1 Oxaliplatin 1 Melatonin 1 Exercise 1 Educational Status 1 Chemoradiotherapy 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03577392 2019-04-04

EXECC

Sichuan Provincial People's Hospital

Phase 2/3 Unknown

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡